Equity (Tables)

9 Months Ended

Jun. 30, 2021

Equity [Abstract]

Schedule of Stock-based Compensation Expense - By Award Type

The effect of recording stock-based compensation expense was as follows:

By Award Type	For the three months ended June 30,				For the nine months ended June 30,
(in thousands)	2021		2020		2021		2020
Employee stock options	$	1	$	4	$	3	$	13
Restricted stock units and awards	573		403		1,505		1,331
Performance stock units and awards	403		255		989		910
Employee stock purchase plan	85		52		258		145
Outside director equity awards and fees in common stock	114		65		255		226
Total stock-based compensation expense	$	1,176	$	779	$	3,010	$	2,625

Schedule of Stock-based Compensation Expense - By Expense Type

By Expense Type	For the three months ended June 30,				For the nine months ended June 30,
(in thousands)	2021		2020		2021		2020
Cost of revenue	$	220	$	166	$	564	$	504
Selling, general, and administrative	752		488		1,830		1,564
Research and development	204		125		616		557
Total stock-based compensation expense	$	1,176	$	779	$	3,010	$	2,625

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of basic and diluted net income (loss) per share:

	For the three months ended June 30,				For the nine months ended June 30,
(in thousands, except per share data)	2021		2020		2021		2020
Numerator:
Income (Loss) from continuing operations	$	13,615	$	(1,287)	$	20,568	$	(7,703)
Undistributed earnings allocated to common stock shareholders for basic and diluted net income (loss) per share	13,615		(1,287)		20,568		(7,703)
Denominator:
Denominator for basic net income (loss) per share - weighted average shares outstanding	36,768		29,295		33,069		29,052
Denominator for fully diluted net (income) loss per share - weighted average shares outstanding	38,893		29,295		34,777		29,052
Net income (loss) per basic share	$	0.37	$	(0.04)	$	0.62	$	(0.27)
Net income (loss) per fully diluted share	$	0.35	$	(0.04)	$	0.59	$	(0.27)
Weighted average antidilutive options, unvested restricted stock units and awards, unvested performance stock units and ESPP shares excluded from the computation	2,138		1,410		1,947		1,316

Schedule of Common Stock Reserved for Future Issuances

As of June 30, 2021, we had common stock reserved for the following future issuances:

	Number of Common Stock Shares Available for Future Issuances
Exercise of outstanding stock options	19,869
Unvested restricted stock units and awards	1,851,187
Unvested performance stock units and awards (at 200% maximum payout)	1,934,000
Purchases under the ESPP	186,197
Issuance of stock-based awards under the Equity Plans	1,774,341
Purchases under the officer and director share purchase plan	88,741
Total reserved	5,854,335